Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

BLEOMYCIN SULFATE

BLEOMYCIN SULFATE

Standard Dose
EQ 15 UNITS BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BLEOMYCIN SULFATE is listed in Drugs@FDA under application 209439 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BLEOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 15 UNITS BASE/VIAL Sponsor CIPLA Submission history Latest submission status date: 2019-03-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview BLEOMYCIN SULFATE is listed in Drugs@FDA under application 209439 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BLEOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 15 UNITS BASE/VIAL Sponsor CIPLA Submission history Latest submission status date: 2019-03-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.